As shown in Figure 8A, B2M was involved in cytokine‐cytokine receptor interactions, proteoglycans in cancer, the NF‐kappa‐B signaling pathway, and the Toll‐like receptor signaling pathway. This evidence concerns the gene B2M and cancer.